Cited by 233Neurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and TreatmentsSubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers

Johanson, Chris-Ellyn, Frey, Kirk A., Lundahl, Leslie H., Keenan, Pamela, Lockhart, Nancy, Roll, John, Galloway, Gantt P., Koeppe, Robert A., Kilbourn, Michael R., Robbins, Trevor, Schuster, Charles R.·2006·Psychopharmacology

DOI 10.1007/s00213-006-0330-6

Open this paper in CoChat — free account

Abstract

Objective Preclinical investigations have established that methamphetamine (MA) produces long-term changes in dopamine (DA) neurons in the striatum. Human studies have suggested similar effects and correlated motor and cognitive deficits. The present study was designed to further our understanding of changes in brain function in humans that might result from chronic high dose use of MA after at least 3 months of abstinence.Method Brain function in abstinent users was compared to controls using neuroimaging of monoamine transporters and cognitive assessment. Striatal levels of DA transporter (DAT) and vesicular monoamine transporter type-2 (VMAT2) were determined using [11C]methylphenidate and [11C]dihydrotetrabenazine positron emission tomography, respectively. Cognitive function was evaluated using tests of motor function, memory, learning, attention, and executive function.Results Striatal DAT was approximately 15% lower and VMAT2 was 10% lower in MA abusers across striatal subregions. The MA abusers performed within the normal range but performed more poorly compared to controls on three of the 12 tasks.Conclusions Failure to find more substantial changes in transporter levels and neurocognitive function may be attributed to the length of time that MA users were abstinent (ranging from 3 months to more than 10 years, mean 3 years), although there were no correlations with length of abstinence. Persistent VMAT2 reductions support the animal literature indicating a toxic effect of MA on nigrostriatal nerve terminals. However, the magnitude of the MA effects on nigrostriatal projection integrity is sufficiently small that it is questionable whether clinical signs of DA deficiency are likely to develop.

Integrity signals

Registry

Crossref · 10.1007/s00213-006-0330-6

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 8,167
Psychopharmacology: The third generation of progress
O’Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,020
Wechsler Adult Intelligence Scale--Third Edition
Wechsler, D. (2019) · PsycTESTS Dataset · doi:10.1037/t49755-000 · Cited by 2,327
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,021
Structured Clinical Interview for DSM-III-R Personality Disorders
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2012) · PsycTESTS Dataset · doi:10.1037/t07827-000 · Cited by 1,403
Cambridge Neuropsychological Test Automated Battery (CANTAB): A Factor Analytic Study of a Large Sample of Normal Elderly Volunteers
Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., McInnes, L., & Rabbitt, P. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106735 · Cited by 1,078
Self-citation
Untitled work
(2001) · Medical Entomology and Zoology · Cited by 1,044
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Leonido–Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., HITZEMANN, R. J., Ding, Y. ‐., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W. W., & London, E. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 770
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Miller, E. N., HITZEMANN, R. J., Ding, Y., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754

Show all 49 references

Sorted by citations

A review of the clinical pharmacology of methamphetamine
Cruickshank, C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 802
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 669
Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 502
Drug Addiction and the Memory Systems of the Brain
Robbins, T. W., Ersche, K. D., & Everitt, B. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.020 · Cited by 467
Self-citation
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse
Chang, L., Alicata, D., Ernst, T. M., & Volkow, N. D. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01782.x · Cited by 433
Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis
Potvin, S., Pelletier, J., Grot, S., Hébert, C., Barr, A. M., & Lecomte, T. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.01.021 · Cited by 368
Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis
Ashok, A. H., Mizuno, Y., Volkow, N. D., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0135 · Cited by 330
Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addictionPreprint
Kutlu, M. G., & Gould, T. J. (2016) · Learning & Memory · doi:10.1101/lm.042192.116 · Cited by 345
Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction
Bickel, W. K., Jarmolowicz, D. P., Mueller, E. T., Gatchalian, K. M., & McClure, S. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2689-x · Cited by 338
An Evaluation of the Evidence that Methamphetamine Abuse Causes Cognitive Decline in Humans
Dean, A. C., Groman, S. M., Morales, A. M., & London, E. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.179 · Cited by 251
Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical Review
Hart, C. L., Marvin, C. B., Silver, R., & Smith, E. E. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.276 · Cited by 242
Gender differences in methamphetamine use and responses: A review
Dluzen, D. E., & Liu, B. (2008) · Gender Medicine · doi:10.1016/s1550-8579(08)80005-8 · Cited by 232
Neuropathology of substance use disorders
Cadet, J. L., Bisagno, V., & Milroy, C. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1221-7 · Cited by 217
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users
McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brašić, J. R., Ye, W., Alexander, M., Dannals, R. F., Wong, D. F., et al. (2007) · Synapse · doi:10.1002/syn.20471 · Cited by 205
In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO
Boileau, I., Payer, D., Chugani, B., Lobo, D. S. S., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., & Zack, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.163 · Cited by 198
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
German, C. L., Baladi, M. G., McFadden, L. M., Hanson, G. R., & Fleckenstein, A. E. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010397 · Cited by 207
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine
Halpin, L. E., Collins, S. A., & Yamamoto, B. K. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.07.014 · Cited by 199
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging
London, E. D., Kohno, M., Morales, A. M., & Ballard, M. E. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.044 · Cited by 192
Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology
Yu, S., Zhu, L., Shen, Q., Bai, X., & Di, X. (2015) · Behavioural Neurology · doi:10.1155/2015/103969 · Cited by 176
Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity
Trifilieff, P., & Martinez, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.031 · Cited by 171
The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment
Ersche, K. D., & Sahakian, B. J. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9033-y · Cited by 175
High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus
Bowyer, J. F., & Ali, S. F. (2006) · Synapse · doi:10.1002/syn.20324 · Cited by 162
Neurologic Manifestations of Chronic Methamphetamine Abuse
Rusyniak, D. E. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.02.005 · Cited by 164
Neuroimaging for drug addiction and related behaviors
Parvaz, M. A., Alia-Klein, N., Woicik, P. A., Volkow, N. D., & Goldstein, R. Z. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.055 · Cited by 151
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Methamphetamine Self-Administration Is Associated with Persistent Biochemical Alterations in Striatal and Cortical Dopaminergic Terminals in the Rat
Krasnova, I. N., Justinová, Z., Ladenheim, B., Jayanthi, S., McCoy, M. T., Barnes, C., Warner, J. E., Goldberg, S. R., & Cadet, J. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008790 · Cited by 139
Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment
Robertson, C. L., Ishibashi, K., Chudzynski, J. E., Mooney, L. J., Rawson, R. A., Dolezal, B. A., Cooper, C. B., Brown, A. K., Mandelkern, M. A., & London, E. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.331 · Cited by 139
Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment
Moszczyńska, A., & Callan, S. P. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.238501 · Cited by 136
Neurologic Manifestations of Chronic Methamphetamine Abuse
Rusyniak, D. E. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.05.004 · Cited by 129
Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence
Simon, S. L., Dean, A. C., Cordova, X., Monterosso, J. R., & London, E. D. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.335 · Cited by 117
Long-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedrone
den Hollander, B., Rozov, S. V., Linden, A.-M., Uusi‐Oukari, M., Ojanperä, I. A., & Korpi, E. R. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.10.006 · Cited by 113
Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence
Iudicello, J. E., Woods, S. P., Vigil, O., Scott, J. C., Cherner, M., Heaton, R. K., Atkinson, J. H., Grant, I., & Ce, T. H. N. R. (2010) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903512637 · Cited by 111
Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches
Cadet, J. L., & Bisagno, V. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00189 · Cited by 110
Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors
Shin, E., Dang, D., Tran, T.-V., Tran, H., Jeong, J. H., Nah, S.-Y., Jang, C., Yamada, K., Nabeshima, T., & Kim, H. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0897-y · Cited by 106
Pharmacotherapeutic agents in the treatment of methamphetamine dependence
Morley, K. C., Cornish, J. L., Faingold, A., Wood, K., & Haber, P. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1313229 · Cited by 111
Substance use disorders in individuals with mild to borderline intellectual disability: Current status and future directions
van Duijvenbode, N., VanDerNagel, J., Didden, R., Engels, R. C. M. E., Buitelaar, J. K., Kiewik, M., & de Jong, C. A. J. (2015) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.12.029 · Cited by 109
A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction
Galloway, G., Buscemi, R., Coyle, J., Flower, K., Siegrist, J. D., Fiske, L. A., Baggott, M., Li, L., Polcin, D., Chen, C.-Y. A., et al. (2010) · Clinical pharmacology and therapy · doi:10.1038/clpt.2010.307 · Cited by 103
Self-citation
Neurocognitive deficits are associated with unemployment in chronic methamphetamine users
Weber, E., Blackstone, K., Iudicello, J., Morgan, E. E., Grant, I., Moore, D. J., & Woods, S. P. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.04.002 · Cited by 102
Genetically Determined Interaction between the Dopamine Transporter and the D2Receptor on Prefronto-Striatal Activity and Volume in Humans
Bertolino, A., Fazio, L., Giorgio, A. D., Blasi, G., Romano, R., Taurisano, P., Caforio, G., Sinibaldi, L., Ursini, G., Popolizio, T., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4858-08.2009 · Cited by 102
Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications
Fleckenstein, A. E., Volz, T. J., & Hanson, G. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.002 · Cited by 100
Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker?
Boileau, I., Rusjan, P., Houle, S., Wilkins, D., Tong, J., Selby, P., Guttman, M., Saint-Cyr, J. A., Wilson, A. A., & Kish, S. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3008-08.2008 · Cited by 100
Effect of methamphetamine dependence on everyday functional ability
Henry, B. L., Minassian, A., & Perry, W. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.01.013 · Cited by 96
Enduring Deficits in Sustained Visual Attention during Withdrawal of Intravenous Methylenedioxymethamphetamine Self-Administration in Rats: Results from a Comparative Study with d-Amphetamine and Methamphetamine
Dalley, J. W., Lääne, K., Theobald, D. E. H., Peña-López, Y., Bruce, C. C., Huszar, A. C., Wojcieszek, M., Everitt, B. J., & Robbins, T. W. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301220 · Cited by 89
Self-citation
Brain serotonin transporter in human methamphetamine users
Kish, S. J., Fitzmaurice, P. S., Boileau, I., Schmunk, G. A., Ang, L.-C., Furukawa, Y., Chang, L., Wickham, D. J., Sherwin, A. L., & Tong, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1346-x · Cited by 93
Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use
Aron, J. L., & Paulus, M. P. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01778.x · Cited by 94
Levels of 4-Hydroxynonenal and Malondialdehyde Are Increased in Brain of Human Chronic Users of Methamphetamine
Fitzmaurice, P. S., Tong, J., Yazdanpanah, M., Liu, P. P., Kalasinsky, K. S., & Kish, S. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109173 · Cited by 89
Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine
Harro, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.004 · Cited by 84
Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway
Hedges, D. M., Obray, J. D., Yorgason, J. T., Jang, E. Y., Weeresekara, V., Uys, J. D. K., Bellinger, F. P., & Steffensen, S. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.291 · Cited by 81
Long-Term Methamphetamine Administration in the Vervet Monkey Models Aspects of a Human Exposure: Brain Neurotoxicity and Behavioral Profiles
Melega, W. P., Jorgensen, M. J., Laćan, G., Way, B. M., Pham, J., Morton, G. G., Cho, A. K., & Fairbanks, L. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301502 · Cited by 78
The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans
Olive, M. F., Taylor, & Lewis (2013) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s39684 · Cited by 87
The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction
Sambo, D. O., Lebowitz, J. J., & Khoshbouei, H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.009 · Cited by 75
Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults
Cherner, M., Suárez, P., Casey, C. Y., Deiss, R., Letendre, S. L., Marcotte, T. D., Vaida, F., Atkinson, J. H., Grant, I., & Heaton, R. K. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.08.010 · Cited by 76
A placebo‐controlled trial of mirtazapine for the management of methamphetamine withdrawal
CRUICKSHANK, C. C., MONTEBELLO, M. E., DYER, K. R., QUIGLEY, A., BLASZCZYK, J., TOMKINS, S., & SHAND, D. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801935672 · Cited by 74
Imaging studies on dopamine transporter and depression: A review of literature and suggestions for future research
Camardese, G., Giuda, D. D., Nicola, M. D., Cocciolillo, F., Giordano, A., Janiri, L., & Guglielmo, R. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.12.006 · Cited by 72
Methamphetamine abuse disturbs the dopaminergic system to impair hippocampal-based learning and memory: An overview of animal and human investigations
Shukla, M., & Vincent, B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.016 · Cited by 73
Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
Rampino, A., Marakhovskaia, A., Soares-Silva, T., Torretta, S., Veneziani, F., & Beaulieu, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00702 · Cited by 72
Neuropsychological deficits in adolescent methamphetamine abusers
King, G., Alicata, D., Cloak, C. C., & Chang, L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1949-x · Cited by 70
Mitochondria: key players in the neurotoxic effects of amphetamines
Barbosa, D. J., Capela, J. P., Feio‐Azevedo, R., Gomes, A., Bastos, M. D. L., & Carvalho, F. D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1478-9 · Cited by 70
Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
McFadden, L. M., Hadlock, G. C., Allen, S. C., Vieira‐Brock, P. L., Stout, K. A., Ellis, J. D., Hoonakker, A. J., Andrenyak, D. M., Nielsen, S. M., Wilkins, D. G., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188433 · Cited by 67
Brain dopamine neurone ‘damage’: methamphetamine users vs. Parkinson's disease – a critical assessment of the evidence
Kish, S. J., Boileau, I., Callaghan, R. C., & Tong, J. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13363 · Cited by 67
Cocaine Abuse in Humans Is Not Associated with Increased Microglial Activation: An 18-kDa Translocator Protein Positron Emission Tomography Imaging Study with [11C]PBR28
Narendran, R., Lopresti, B. J., Mason, N. S., Deuitch, L., Paris, J., Himes, M. L., Kodavali, C. V., & Nimgaonkar, V. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0928-14.2014 · Cited by 66
Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers
Newton, T. F., Reid, M. S., Garza, R. D. L., Mahoney, J. J., Abad, A., Condos, R., Palamar, J. J., Halkitis, P. N., Mojisak, J., Anderson, A., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009097 · Cited by 61
Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits
Bisagno, V., González, B., & Urbano, F. J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.013 · Cited by 59
Ammonia Mediates Methamphetamine-Induced Increases in Glutamate and Excitotoxicity
Halpin, L. E., Northrop, N. A., & Yamamoto, B. K. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.306 · Cited by 58
Withdrawal from chronic treatment with methamphetamine induces anxiety and depression-like behavior in mice
Ru, Q., Xiong, Q., Zhou, M., Chen, L., Tian, X., Xiao, H., Li, Z., & Li, Y. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.11.072 · Cited by 59
Monoamine Transporter Inhibitors and Substrates as Treatments for Stimulant Abuse
Howell, L. L., & Negus, S. S. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00004-4 · Cited by 56
Striatal Volume Increases in Active Methamphetamine-Dependent Individuals and Correlation with Cognitive Performance
Jan, R. K., Lin, J. C., Miles, S. W., Kydd, R. R., & Russell, B. (2012) · Brain Sciences · doi:10.3390/brainsci2040553 · Cited by 57
8.3 Imaging Dopamine’s Role in Drug Abuse and Addiction
Volkow, N. D., Fowler, J. S., Wang, G., Telang, F., & Baler, R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0028 · Cited by 58
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers
Narendran, R., Lopresti, B. J., Martinez, D., Mason, N. S., Himes, M., May, M. A., Daley, D. C., Price, J. C., Mathis, C. A., & Frankle, W. G. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010126 · Cited by 53
Abnormal Striatal Circuitry and Intensified Novelty Seeking among Adolescents Who Abuse Methamphetamine and Cannabis
Churchwell, J. C., Carey, P. D., Ferrett, H. L., Stein, D. J., & Yurgelun-Todd, D. A. (2012) · Developmental Neuroscience · doi:10.1159/000337724 · Cited by 52
Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies
Proebstl, L., Kamp, F., Manz, K., Krause, D., Adorjan, K., Pogarell, O., Koller, G., Soyka, M., Falkai, P., & Kambeitz, J. (2019) · European psychiatry · doi:10.1016/j.eurpsy.2019.03.003 · Cited by 52
Role of microglia in methamphetamine-induced neurotoxicity.
Xu, E., Liu, J., Liu, H., Wang, X., & Xiong, H. (2017) · Europe PMC (PubMed Central) · Cited by 52
Functional and Structural Brain Changes Associated with Methamphetamine Abuse
Jan, R. K., Kydd, R. R., & Russell, B. R. (2012) · Brain Sciences · doi:10.3390/brainsci2040434 · Cited by 52
Compulsivity Across the Pathological Misuse of Drug and Non-Drug Rewards
Banca, P., Harrison, N. A., & Voon, V. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00154 · Cited by 52
Assessment of Executive Functions in Methamphetamineaddicted Individuals: Emphasis on Duration of Addiction and Abstinence
Farhadian, M., Akbarfahimi, M., Hassani‐Abharian, P., Hosseini, S. G., & Shokri, S. (2017) · Basic and Clinical Neuroscience Journal · doi:10.18869/nirp.bcn.8.2.147 · Cited by 51
Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research
Guerin, A. A., Bonomo, Y. A., Lawrence, A. J., Baune, B. T., Nestler, E. J., Rossell, S. L., & Kim, J. H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00880 · Cited by 50
Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana
Sung, Y., Carey, P. D., Stein, D. J., Ferrett, H. L., Spottiswoode, B. S., Renshaw, P. F., & Yurgelun-Todd, D. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.028 · Cited by 45
Translatable and Back-Translatable Measurement of Impulsivity and Compulsivity: Convergent and Divergent Processes
Voon, V., & Dalley, J. W. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5013 · Cited by 46
Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials
Acheson, L. S., Williams, B. H., Farrell, M., McKetin, R., Ezard, N., & Siefried, K. J. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13511 · Cited by 47
Striatal dopamine D1 and D2 receptors: Widespread influences on methamphetamine‐induced dopamine and serotonin neurotoxicity
Gross, N. B., Duncker, P. C., & Marshall, J. F. (2011) · Synapse · doi:10.1002/syn.20952 · Cited by 44
Dopamine modulating drugs influence striatal (+)‐[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration
Tong, J., Wilson, A. A., Boileau, I., Houle, S., & Kish, S. J. (2008) · Synapse · doi:10.1002/syn.20573 · Cited by 44
A Single Neurotoxic Dose of Methamphetamine Induces a Long-Lasting Depressive-Like Behaviour in Mice
Silva, C., Neves, A. F., Dias, A. I., de Freitas, H. J. F., Mendes, S. M., Pita, I. R., Viana, S., de Oliveira, P. A., Cunha, R. A., Ribeiro, C., et al. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9423-2 · Cited by 43
Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice
Grace, C. E., Schaefer, T. L., Herring, N. R., Graham, D. L., Skelton, M. R., Gudelsky, G. A., Williams, M. T., & Vorhees, C. V. (2010) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2010.01.006 · Cited by 42
Environmental enrichment reduces methamphetamine cue-induced reinstatement but does not alter methamphetamine reward or VMAT2 function
Hofford, R. S., Darna, M., Wilmouth, C. E., Dwoskin, L. P., & Bardo, M. T. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.007 · Cited by 42
A neurotoxic regimen of methamphetamine impairs novelty recognition as measured by a social odor-based task
O’Dell, S. J., Feinberg, L. M., & Marshall, J. F. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.022 · Cited by 41
Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling
London, E. D. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.002 · Cited by 42
A meta-analysis of the relationship between abstinence and neuropsychological functioning in methamphetamine use disorder.
Basterfield, C., Hester, R., & Bowden, S. C. (2019) · Neuropsychology · doi:10.1037/neu0000552 · Cited by 43
Methamphetamine Preconditioning: Differential Protective Effects on Monoaminergic Systems in the Rat Brain
Cadet, J. L., Krasnova, I. N., Ladenheim, B., Cai, N.-S., McCoy, M. T., & Atianjoh, F. E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9026-0 · Cited by 40
Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior
Saloner, R., Fields, J. A., Marcondes, M. C. G., Iudicello, J. E., von Känel, S., Cherner, M., Letendre, S. L., Kaul, M., & Grant, I. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09957-0 · Cited by 40
Biological substrates of addiction
Joffe, M. E., Grueter, C. A., & Grueter, B. A. (2014) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1273 · Cited by 42
Pattern and related factors of cognitive impairment among chronic methamphetamine users
Wang, T., Fan, T., Bao, Y., Li, X.-D., Liang, C., Wang, R., Ma, J., Han, Y., Meng, S., Wu, P., et al. (2017) · American Journal on Addictions · doi:10.1111/ajad.12505 · Cited by 39
Decreased cortical complexity in methamphetamine abusers
Yun, K., Park, H.-K., Kwon, D.-H., Kim, Y., Cho, S., Cho, H.-J., Peterson, B. S., & Jeong, J. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.07.009 · Cited by 38
Working Memory and Speed of Information Processing in Chronic Khat Users: Preliminary Findings
Hoffman, R., & Al’Absi, M. (2012) · European Addiction Research · doi:10.1159/000338285 · Cited by 38
Neurologic Complications of Psychomotor Stimulant Abuse
Sanchez‐Ramos, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.003 · Cited by 40
Aripiprazole as a potential pharmacotherapy for stimulant dependence: Human laboratory studies with d-amphetamine.
Stoops, W. W. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.4.413 · Cited by 38
Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal
Ren, W., Luan, X., Zhang, J., Gutteea, P., Cai, Y., Zhao, J., Gu, Y., Wu, C., Su, H., Tao, J., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.017 · Cited by 39
Neuropsychological comparisons of cocaine versus methamphetamine users: A research synthesis and meta-analysis
Hall, M. G., Hauson, A. O., Wollman, S. C., Allen, K. E., Connors, E. J., Stern, M. J., Kimmel, C. L., Stephan, R. A., Sarkissians, S., Barlet, B. D., et al. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1355919 · Cited by 40
Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls
Wang, L., Chen, C., Lin, S., Chen, Y., Xu, K., & Huang, M. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4910-z · Cited by 36
Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
Graves, S. M., Schwarzschild, S. E., Tai, R., Chen, Y., & Surmeier, D. J. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105409 · Cited by 40

Authors: Johanson, C.-E., Frey, K. A., Lundahl, L. H., Keenan, P., Lockhart, N., Roll, J., Galloway, G. P., Koeppe, R. A., Kilbourn, M. R., Robbins, T., & Schuster, C. R.
Affiliations: Wayne State University (US)
University of Michigan (US)
Friends Research Institute (US)
University of Cambridge (GB)
Corresponding author: Johanson, Chris-Ellyn
ORCID: Frey, Kirk A.
Lundahl, Leslie H.
Lockhart, Nancy
Roll, John
Koeppe, Robert A.
Kilbourn, Michael R.
Robbins, Trevor
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2006-03-03
Volume: 185
Issue: 3
Pages: 327-338
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-006-0330-6
OpenAlex: W1973774749
Cited by: 233
References: 49
Citations by year: 2026: 2 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 11 · 2020: 30 · 2019: 8 · 2018: 9 · 2017: 12 · 2016: 11 · 2015: 15 · 2014: 12 · 2013: 19 · 2012: 21
FWCI: 4.40
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Deep Blue (University of Michigan) (submittedVersion)
Funders: National Institutes of Health (5r01da012458-03, 5r21da014392-02)
National Institute on Drug Abuse (DA14392, DA12458, R01DA010641, R01 DA10641)
National Institute of Neurological Disorders and Stroke (NS-15655)
National Center for Research Resources (RR00042, M01RR000042)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords: methamphetamine, abstinence, cognitive function, nigrostriatal pathway, dopamine transporter, vesicular monoamine transporter 2, striatum, dopamine deficiency, monoamine transporters, executive function, learning and memory, attention, motor function
MeSH terms: Adolescent, Adult, Cognition, Corpus Striatum, Dopamine, Female, Humans, Male, Methamphetamine, Middle Aged, Psychological Tests, Substantia Nigra, Amphetamine-Related Disorders, Dopamine Plasma Membrane Transport Proteins, Vesicular Monoamine Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks